SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells

Molecular Therapy

Volumn 23, Issue 1, 2015, Pages 158-170

  Toscano, Miguel G ^a,d   Navarro Montero, Oscar ^a   Ayllon, Veronica ^a   Ramos Mejia, Veronica ^a   Guerrero Carreno, Xiomara ^a   Bueno, Clara ^a,b   Romero, Tamara ^a   Lamolda, Mar ^a   Cobo, Marien ^a   Martin, Francisco ^a   Menendez, Pablo ^a,b,c   Real, Pedro J ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^d Amarna Therapeutics SL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; TRANSCRIPTION FACTOR TAL1; TRICHOSTATIN A; VALPROIC ACID; VORINOSTAT; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CD34 ANTIGEN; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; ONCOPROTEIN; TAL1 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; COLONY FORMING UNIT; CONNECTOME; CYTOCHEMISTRY; DRUG EFFECT; EMBRYONIC STEM CELL; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MEGAKARYOCYTE; MEGAKARYOPOIESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; THROMBOCYTE; THROMBOCYTOPOIESIS; CELL CULTURE; CELL LINEAGE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PLASMID; PROTEIN ANALYSIS;

ANTIGENS, CD34; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOOD PLATELETS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; MEGAKARYOCYTES; PLASMIDS; PROTEIN INTERACTION MAPPING; PROTO-ONCOGENE PROTEINS; THROMBOPOIESIS; TRANSCRIPTION, GENETIC; VALPROIC ACID;

EID: 84920678486     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2014.196     Document Type: Article

References (50)

1. Kaushansky, K (2008). Historical review: megakaryopoiesis and thrombopoiesis. Blood 111: 981-986.
2. Slichter, SJ (2004). Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev 18: 153-167.
3. Lambert, MP, Sullivan, SK, Fuentes, R, French, DL and Poncz, M (2013). Challenges and promises for the development of donor-independent platelet transfusions. Blood 121: 3319-3324.
4. Tao, H, Gaudry, L, Rice, A and Chong, B (1999). Cord blood is better than bone marrow for generating megakaryocytic progenitor cells. Exp Hematol 27: 293-301.
5. De Bruyn, C, Delforge, A, Martiat, P and Bron, D (2005). Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. Stem Cells Dev 14: 415-424.
6. Kimbrel, EA and Lu, SJ (2011). Potential clinical applications for human pluripotent stem cell-derived blood components. Stem Cells Int 2011: 273076.
7. Takayama, N, Nishikii, H, Usui, J, Tsukui, H, Sawaguchi, A, Hiroyama, T et al. (2008). Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 111: 5298-5306.
8. Takayama, N, Nishimura, S, Nakamura, S, Shimizu, T, Ohnishi, R, Endo, H et al. (2010). Transient activation of c-MYC expression is critical for effcient platelet generation from human induced pluripotent stem cells. J Exp Med 207: 2817-2830.
9. Lu, SJ, Li, F, Yin, H, Feng, Q, Kimbrel, EA, Hahm, E et al. (2011). Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res 21: 530-545.
10. Pick, M, Azzola, L, Osborne, E, Stanley, EG and Elefanty, AG (2013). Generation of megakaryocytic progenitors from human embryonic stem cells in a feeder-and serum-free medium. PLoS One 8: e55530.
11. Tijssen, MR and Ghevaert, C (2013). Transcription factors in late megakaryopoiesis and related platelet disorders. J Thromb Haemost 11: 593-604.
12. Goldfarb, AN (2009). Megakaryocytic programming by a transcriptional regulatory loop: a circle connecting RUNX1, GATA-1, and P-TEFb. J Cell Biochem 107: 377-382.
13. Shivdasani, RA, Mayer, EL and Orkin, SH (1995). Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 373: 432-434.
14. Mikkola, HK, Klintman, J, Yang, H, Hock, H, Schlaeger, TM, Fujiwara, Y et al. (2003). Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 421: 547-551.
15. Hall, MA, Curtis, DJ, Metcalf, D, Elefanty, AG, Sourris, K, Robb, L et al. (2003). The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12. Proc Natl Acad Sci USA 100: 992-997.
16. Yung, S, Ledran, M, Moreno-Gimeno, I, Conesa, A, Montaner, D, Dopazo, J et al. (2011). Large-scale transcriptional profling and functional assays reveal important roles for Rho-GTPase signalling and SCL during haematopoietic differentiation of human embryonic stem cells. Hum Mol Genet 20: 4932-4946.
17. Real, PJ, Ligero, G, Ayllon, V, Ramos-Mejia, V, Bueno, C, Gutierrez-Aranda, I et al. (2012). SCL/TAL1 regulates hematopoietic specifcation from human embryonic stem cells. Mol Ther 20: 1443-1453.
18. Liu, B, Ohishi, K, Yamamura, K, Suzuki, K, Monma, F, Ino, K et al. (2010). A potential activity of valproic acid in the stimulation of interleukin-3-mediated megakaryopoiesis and erythropoiesis. Exp Hematol 38: 685-695.
19. Croft, D, O'Kelly, G, Wu, G, Haw, R, Gillespie, M, Matthews, L et al. (2011). Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res 39(Database issue): D691-D697.
20. Gurney, AL, Carver-Moore, K, de Sauvage, FJ and Moore, MW (1994). Thrombocytopenia in c-mpl-defcient mice. Science 265: 1445-1447.
21. Labbaye, C, Quaranta, MT, Pagliuca, A, Militi, S, Licht, JD, Testa, U et al. (2002). PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein. Oncogene 21: 6669-6679.
22. Jackers, P, Szalai, G, Moussa, O and Watson, DK (2004). Ets-dependent regulation of target gene expression during megakaryopoiesis. J Biol Chem 279: 52183-52190.
23. Huang, H, Yu, M, Akie, TE, Moran, TB, Woo, AJ, Tu, N et al. (2009). Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. Mol Cell Biol 29: 4103-4115.
24. Zhong, Y, Sullenbarger, B and Lasky, LC (2010). Effect of increased HoxB4 on human megakaryocytic development. Biochem Biophys Res Commun 398: 377-382.
25. Smith, EC, Thon, JN, Devine, MT, Lin, S, Schulz, V P, Guo, Y et al. (2012). MKL1 and MKL2 play redundant and crucial roles in megakaryocyte maturation and platelet formation. Blood 120: 2317-2329.
26. Tijssen, MR, Cvejic, A, Joshi, A, Hannah, RL, Ferreira, R, Forrai, A et al. (2011). Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifes hematopoietic regulators. Dev Cell 20: 597-609.
27. Tsang, A P, Visvader, JE, Turner, CA, Fujiwara, Y, Yu, C, Weiss, MJ et al. (1997). FOG, a multitype zinc fnger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90: 109-119.
28. Tsang, A P, Fujiwara, Y, Hom, DB and Orkin, SH (1998). Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev 12: 1176-1188.
29. Lamb, J, Crawford, ED, Peck, D, Modell, JW, Blat, IC, Wrobel, MJ et al. (2006). The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313: 1929-1935.
30. Shivdasani, RA (2001). Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells 19: 397-407.
31. Moussa, O, LaRue, AC, Abangan, RS Jr, Williams, CR, Zhang, XK, Masuya, M et al. (2010). Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1. Mol Cell Biol 30: 5194-5206.
32. Ichikawa, M, Asai, T, Saito, T, Seo, S, Yamazaki, I, Yamagata, T et al. (2004). AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med 10: 299-304.
33. Chagraoui, H, Kassouf, M, Banerjee, S, Goardon, N, Clark, K, Atzberger, A et al. (2011). SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis. Blood 118: 723-735.
34. Elwood, NJ, Zogos, H, Pereira, DS, Dick, JE and Begley, CG (1998). Enhanced megakaryocyte and erythroid development from normal human CD34(+) cells: consequence of enforced expression of SCL. Blood 91: 3756-3765.
35. Valtieri, M, Tocci, A, Gabbianelli, M, Luchetti, L, Masella, B, Vitelli, L et al. (1998). Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program. Cancer Res 58: 562-569.
36. Calkhoven, CF, Muller, C, Martin, R, Krosl, G, Pietsch, H, Hoang, T et al. (2003). Translational control of SCL-isoform expression in hematopoietic lineage choice. Genes Dev 17: 959-964.
37. Pevny, L, Simon, MC, Robertson, E, Klein, WH, Tsai, SF, D'Agati, V et al. (1991). Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349: 257-260.
38. Shivdasani, RA, Fujiwara, Y, McDevitt, MA and Orkin, SH (1997). A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J 16: 3965-3973.
39. Millikan, PD, Balamohan, SM, Raskind, WH and Kacena, MA (2011). Inherited thrombocytopenia due to GATA-1 mutations. Semin Thromb Hemost 37: 682-689.
40. Shimizu, R and Yamamoto, M (2012). Contribution of GATA1 dysfunction to multi-step leukemogenesis. Cancer Sci 103: 2039-2044.
41. Tanaka, Y, Joshi, A, Wilson, NK, Kinston, S, Nishikawa, S and Göttgens, B (2012). The transcriptional programme controlled by Runx1 during early embryonic blood development. Dev Biol 366: 404-419.
42. Lim, SY, Sivakumaran, P, Crombie, DE, Dusting, GJ, Pébay, A and Dilley, RJ (2013). Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering. Stem Cells Transl Med 2: 715-725.
43. Palii, CG, Vulesevic, B, Fraineau, S, Pranckeviciene, E, Griffth, AJ, Chu, A et al. (2014). Trichostatin A enhances vascular repair by injected human endothelial progenitors through increasing the expression of TAL1-dependent genes. Cell Stem Cell 14: 644-657.
44. Vulcano, F, Ciccarelli, C, Mattia, G, Marampon, F, Giampiero, M, Milazzo, L et al. (2006). HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers. Exp Cell Res 312: 1590-1597.
45. Chagraoui, H and Porcher, C (2012). Establishment of an ES cell-derived murine megakaryocytic cell line, MKD1, with features of primary megakaryocyte progenitors. PLoS One 7: e32981.
46. Huang, S and Brandt, SJ (2000). mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor. Mol Cell Biol 20: 2248-2259.
47. Huang, S, Qiu, Y, Shi, Y, Xu, Z and Brandt, SJ (2000). P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL. EMBO J 19: 6792-6803.
48. Nishikii, H, Eto, K, Tamura, N, Hattori, K, Heissig, B, Kanaji, T et al. (2008). Metalloproteinase regulation improves in vitro generation of effcacious platelets from mouse embryonic stem cells. J Exp Med 205: 1917-1927.
49. Bueno, C, Ayllón, V, Montes, R, Navarro-Montero, O, Ramos-Mejia, V, Real, PJ et al. (2013). FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specifcation of human ESCs. Blood 121: 3867-3878, S1.
50. Subramanian, A, Tamayo, P, Mootha, VK, Mukherjee, S, Ebert, BL, Gillette, MA et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profles. Proc Natl Acad Sci USA 102: 15545-15550.